Biosynthetic and synthetic AChR sequences to study T cells in myasthenia gravis.
Biosynthetic and synthetic AChR sequences to study T cells in myasthenia gravis.
复制标题
用于研究重症肌无力 T 细胞的生物合成和合成 AChR 序列。
DOI:
10.1111/j.1749-6632.1998.tb10938.x
复制
发表时间:
1998
影响因子:
5.2
通讯作者:
Conti-Fine,BM
中科院分区:
文献类型:
--
作者:
Diethelm-Okita,B;Wells,G;Kuryatov,A;Okita,D;Howard,J;Lindstrom,J;Conti-Fine,BM
Antigen (Ag)–specific T cell lines and clones are important tools to understand the molecular interactions occurring in the T cell compartment in both normal and autoimmune responses. Propagation in vitro of polyclonal cell lines specific for a given Ag yields populations of T cells enriched in Ag-specific cells and allows studies on the Ag sequence regions forming T epitopes. Such studies would be of dubious success if using unselected blood CD4+ cells, given the low frequency of T cells specific for one individual epitope. 1, 2 Also, Ag-specific T cell lines and clones are necessary to investigate the functional properties of the CD4+ cells recognizing a given Ag or epitope, as well as the structural properties of their T cell receptor. For human autoimmune diseases involving autoantigens (autoAg) of known identity and sequence, given the scarcity of the relevant autoAg, synthetic and biosynthetic autoAg sequences have been used to propagate specific T cell lines. Anti-AChR CD4+ T cells from myasthenia gravis (MG) patients have been studied using synthetic or recombinant AChR sequences, sometimes yielding inconsistent results and raising questions about the suitability of those AChR Ag for the study of T cells. 1, 3